StockWatch
·
Healthcare Service Provider
Board Meeting3 Nov 2026, 04:10 pm

Samsrita Labs Board Meeting on Nov 11 to Approve Q2 Results

AI Summary

Samsrita Labs Ltd has announced that its Board of Directors will convene on November 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, along with the limited review report. The meeting is scheduled for 3:30 PM at their Hyderabad office. Additionally, the company has informed that the trading window for dealing in its securities will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 11, 2026.
  • To approve unaudited standalone and consolidated financial results.
  • Results for the quarter and half-year ended September 30, 2026.
  • Trading window closed for insiders until results are declared.